- Article
Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy
- Athika Darumas Putri,
- Pai-Shan Chen,
- Yu-Lin Su,
- Jia-Pei Lin,
- Jing-Ping Liou and
- Chien-Ming Hsieh
Histone deacetylase (HDAC) inhibitors have emerged as a new class of antitumor agent for various types of tumors. MPT0B291, a novel selective inhibitor of HDAC6, demonstrated significant antiproliferative activity in various human cancer cell types....

